Home / Psoriasis / Risk of uncommon cancers in patients with psoriasis

Risk of uncommon cancers in patients with psoriasis



Cancer-associated mortality is increased in psoriasis. However, little is known about the risk of less common cancers.


We aimed to evaluate the risk of less common cancers in patients with psoriasis compared to persons without psoriasis using a nationwide cohort study.


Between January 1st 2008 and December 31st 2012, we identified all Danish patients with a first-time hospital diagnosis of a less common cancer defined as <100 new cases/year/100.000 persons in Denmark. The primary endpoint was the occurrence of a diagnosis of cancer.


We included 4,361,869 individuals. Of these, 58,138 were classified as having psoriasis. After adjusting for age, sex, socioeconomic status, and health care consumption, we found significantly elevated hazard ratios for cancers of bone and cartilage (HR 4.97 [2.32-10.62], P<0.0001) in patients with psoriasis on systemic treatment.


We provide further evidence of an increased cancer of bone and cartilage risk in patients with psoriasis.

Full Article

About Dr. J. Kim

Dr Kim developed (and is continuing to develop) dermatology research news as we way from dermatologists to stay on top of the latest advances in the field of dermatology.

Check Also

A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-1)

Study Description Go to  Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information Brief Summary: The purpose of this study is to evaluate the efficacy and safety of mirikizumab in participants with moderate to severe plaque psoriasis. Condition or disease Intervention/treatment Phase Psoriasis Drug: Mirikizumab Drug: Placebo Phase 3 …

Leave a Reply

Your email address will not be published. Required fields are marked *